W.L.Gore & Associates
gore.comTotal trials
94
Active
38
Phase 3
4
Total enrollment
23,884
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Aortic Aneurysm, Thoracic7
- Peripheral Arterial Disease6
- Peripheral Vascular Diseases5
- Aortic Aneurysm, Abdominal4
- Thoracic Aortic Aneurysm4
- Thoracoabdominal Aortic Aneurysm4
- Venous Thromboses3
- Venous Disease3
Frequently asked questions about W.L.Gore & Associates
- How many clinical trials does W.L.Gore & Associates have on ClinicalTrials.gov?
- W.L.Gore & Associates is listed as the lead sponsor on 94 clinical trials in ClinicalTrials.gov, 38 of which are currently active (recruiting, enrolling, or ongoing).
- How many of W.L.Gore & Associates's trials are in Phase 3?
- 4 of W.L.Gore & Associates's trials are in Phase 3.
- What therapeutic areas does W.L.Gore & Associates focus on?
- W.L.Gore & Associates's most-studied conditions on ClinicalTrials.gov are Aortic Aneurysm, Thoracic, Peripheral Arterial Disease, Peripheral Vascular Diseases, Aortic Aneurysm, Abdominal, Thoracic Aortic Aneurysm.